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Hepatitis B virus (HBV) is a causative agent for liver diseases including hepatocellular carcinoma. Understanding its interactions with cellular
proteins is critical in the elucidation of the mechanisms of disease progression. Using a cell-based HBV replication system, we showed that HBV
replication in HepG2 cells resulted in a cellular morphological changes displaying membrane rufflings and lamellipodia like structures reminiscent
of cells expressing constitutively activated Rac1. We also showed that activated Rac1 resulted in increased viral replication. HBV replication
specifically activated wild type Rac1, but not Cdc42. The Rac1 activation by HBV replication also resulted in the phosphorylation of ERK1/2 and
AKT, the downstream targets of Rac1 signaling cascade. The smallest HBV viral protein, HBX, was able to activate the endogenous Rac1 and
induce membrane ruffling when transfected into cells. Significantly, HBX was found to directly interact with a Rac1 nucleotide exchange factor
(βPIX) through a SH3 binding motif. Taken together, we have shown the interaction of HBV with the Rho GTPase, affecting cell morphology
through the Rac1 activation pathway. HBV may possibly make use of an activated Rac1 signaling pathway for increased replication and resultant
metastatic effects.
© 2007 Elsevier B.V. All rights reserved.Keywords: Hepatitis B virus replication; Rac1 activation; Cell morphology; HBX; βPIX1. Introduction
Hepatitis B virus (HBV) causes acute and chronic hepatitis
with an increased risk of liver diseases including hepatocellular
carcinoma (HCC) [1]. Like many other viruses, HBV replica-
tion is an intricate process requiring specific interactions
between the virus and host's cellular proteins allowing the
virus to make use of the cellular machinery efficiently for their
viral protein production and packaging. The elucidation of
cellular responses upon viral infection is critical for designing
effective antiviral therapy. Viral infections have been shown to⁎ Corresponding authors. School of Chemical and Biomedical Engineering,
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doi:10.1016/j.bbamcr.2007.10.024result in filopodia and lamellipodia formation for triggering cell
migration as a way of infection defense [2,3] and deregulation
of this normal cellular mechanism might lead to malignancy
onset. The formation of these structures is mainly regulated by
the Rho family of small GTP-binding proteins, Cdc42, Rac1
and RhoA, known as Rho GTPases. They have been known to
regulate several cellular functions such as adhesion, polariza-
tion, spreading, migration, gene expression, and endocytosis as
well as cell growth. Specifically, Cdc42 induces filopodia
formation to regulate cell polarity while Rac1 induces
membrane rufflings and lamellipodia formation. RhoA induces
formation of stress fibers [4–7]. Previous investigations have
associated Rho GTPases with virus replication. For example,
Cdc42 and Rac1 activation have been linked to increased HIV-1
replication [8]. Regulation of Rac1 and Cdc42 activation have
been found to be critical in early Herpes simplex virus type I
infection and in particular, cells producing the dominant
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bound state) resulted in a drastic decrease in HSV-1 viral
infectivity [9]. Importantly, HBX have been shown to enhance
cell motility and induce migratory phenotype through a CD44-
dependent manner by rearrangements of F-actin possibly
through a Rho- and/or Rac-dependent pathway [10]. It is
hence not surprising that viruses can make use of host
cytoskeletal control modules in an attempt to control their
replication or viral protein trafficking. Activation and dissocia-
tion of Rho GTPases are modulated by the guanine nucleotide
exchange factor (RhoGEF) and GTPases activating protein
(RhoGAP) respectively. While remaining mostly at its inactive
GDP-bound form by RhoGDI, activation of the Rac1 is
regulated by guanine nucleotide exchange factors (GEFs)
following the dissociation of GDI complex [11]. It has been
shown that one of the Rho GEFs, βPIX, is critical for the
activation of Rac1 resulting in its downstream signaling
pathway and morphological presentation [12]. Here, we
observed by atomic force microscopy and immunostaining
fluorescent microscopy the similarity between HBV replicating
cells and activated Rac1-GTP induced morphological changes
in HepG2 cells. We have also demonstrated the specific
activation of Rac1 by HBV replication and showed that
activated Rac1 can result in an increased viral yield as indicated
by the increase in viral replication intermediates. Our result
strongly suggests that increased HBV replication is tightly
coupled to Rac1 activation. We further demonstrated that the
maintenance of Rac1 activation leading to increased viral
replication might be attributed to HBx interaction with βPIX.
2. Materials and methods
2.1. Plasmids
HBV viral DNA was extracted and subsequently cloned into pCDNA3.1+
mammalian expression vector (Invitrogen Inc., USA) before the CMV promoter,
with terminal redundancy 1600–1900 bp forming a 1.1X HBV length construct.
This was used for transfection of mammalian cell culture [13]. GST-PAK 1–
207 aa FLAG were constructed by cloning of the PAK1 N-terminal 207 aa into
pGEX vector with a FLAG tag. This region of the PAK1 consists of the Cdc42 /
Rac1 Interactive Binding (CRIB) domain as well as the βPIX binding proline-
rich motif. Constitutively activated mutants and dominant negative mutants of
Cdc42, Rac1 and RhoAwere cloned in pXJ40HA mammalian expression vector
containing an N-terminal HA tag. HBX was cloned into pEGFP-C1 (Clontech)
with GFP as N-terminal fusion protein. Partial fragment of HBX (amino acids
28–58 RP29LPGP29LGALPPASP42P43IVPTDHGAHLSLRGL) were cloned in
fusion with GST to form the GST-PXXP region. Site-directed mutagenesis were
made use of for generating the GST-AXXA construct where relatively inert
alanines were substituted for the proline residues highlighted.
2.2. Cell culture and transfection
HepG2 (ATCC, USA) and HEK293T (ATCC, USA) cells were maintained
in Gibco's Dulbecco's Minimal Essential Medium (Invitrogen Inc.,USA),
supplemented with 10% fetal bovine serum (Invitrogen Inc.,USA), 1% anti-
mycotic (Invitrogen Inc.,USA) under 37 °C and 5% CO2. HepG2.2.15 [14] was
maintained in DMEM, supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, 100 μg/ml streptomycin, 2 mM glutamine, 1 mM sodium pyruvate
and 0.1 mM MEM nonessential amino acids under 37 °C and 5% CO2.
Passaging of the cells were performed at approximately 80% confluency every
other day to maintain their integrity. Transfection of HEK293Tcells were carried
out using Effectene transfection reagent (QIAGEN, USA) according to themanufacturer's instructions. Briefly, 3×105 cells were seeded onto each well of
a 6-well plate 16 h prior to transfection. 1 μg of plasmid DNAmixed with 8 μl of
enhancer were incubated for 5 min prior to addition of 20 μl of Effectene
Transfection Reagent. After incubation for a further 10 min, the transfection
complex were mixed with 500 μl of fresh medium and added slowly to the cells.
The cells were kept at 37 °C 5% CO2 for 2 h followed by change of fresh
medium. Cells were then incubated for 48 h and lysed for protein or RNA
extraction. Transfection of HepG2 cells were carried out on a Nucleofector
machine (Amaxa, GmBH) utilizing Nucleofector solution V. Briefly, 1.5×106
HepG2 cells were resuspended in 100 μl of solution V. 2 μg of plasmids were
added and transferred into the specialized cuvettes provided. Nucleofection was
carried out using Program T-28 (HepG2 high efficiency). 500 μl of prewarmed
medium was added to the nucleofected mix and carefully transferred onto
60 mm tissue culture dishes. The transfected cells were allowed to adhere by
incubation at 37 °C 5% CO2 for 4 h. Non-adherence cells and transfection mix
were aspirated and fresh medium were added. Cells were then incubated for 48 h
and used for protein or RNA extraction.
2.3. Atomic force microscope
HepG2 cells transfected with replicative HBV genome were first washed
with 1× PBS for 1 min followed by fixation with 3% Paraformaldehyde/PBS for
20 min The fixed cells were then washed with 1× PBS twice (10 min each)
followed by excision of the base of the culture dish to achieve a planar plain for
AFM analysis. All samples were investigated with NanoMan AFM (Veeco
Instruments, USA) with tapping mode under air. A cantilever with a resonance
frequency of 274 kHz and a scan rate of 0.5 Hz was used in all experiments.
Both topographic image and amplitude images were simultaneously recorded.
Each AFM topographic or amplitude image is a representative view of at least
3 samples (at least five regions of interests in each sample) and is highly
reproducible under the same procedures of sample preparation. Data analyses
were performed using the Nanoscope software (Veeco Instruments, USA).
2.4. Immunofluorescent staining of actin filaments
Empty vector, HBV replicative genome, Rac1G12V, and Cdc42G12V
transfected HepG2 cells (Nucleofection) seeded on glass-bottom culture dishes
(Iwaki, Japan), were washed with prewarmed 1× PBS (Invitrogen Inc., USA)
and fixed with 1 ml of 3% Paraformaldehyde/PBS for 20 min. This was followed
by another wash in 1× PBS for 10 min prior to permeabilization with 0.2%
Triton-X100/1× PBS. Blocking was then performed using 10% FBS/0.1%
Triton-X100/1× PBS followed by a wash in PBS. Cells were incubated with
Phalloidin-alexa fluor 488 nm (Molecular Probes) at 37 °C for 2 h. After
washing with 0.1% Triton-X100/1× PBS twice for 15 min, the glass-bottom
dishes were air dried prior to observation using Olympus IX71 inverted
fluorescent microscope.
2.5. CRIB binding assay
PAK1 Cdc42/Rac1 interactive binding (CRIB) domain, spanning aa 75–90,
interacts specifically with activated Rho GTPases, Cdc42-GTP and Rac1-GTP
specifically [13]. The GST-PAK1 1–207 aa construct containing the CRIB was
used. Wild Type (WT), constitutively active and negative constructs of Cdc42
and Rac1 cloned in pXJ40HA, with an N-terminal HA tag, were as previously
described [16]. Briefly, V12 and N17 constructs represent the constitutively
active and negative mutant respectively. All constructs could be detected by
more monoclonal anti-HA (F-7) antibodies (Santa Cruz Biotech). Briefly,
HEK293 T cells were co-transfected with HBV replicative genome and the Rac1
or Cdc42 constructs. 48 h post-transfection, total protein was obtained by
homogenization in lysis buffer (50 mM Tris–Cl pH 8.0, 150 mM NaCl, 1%
Triton-X100) supplemented with complete protease inhibitor cocktail (Roche)
and supernatant containing the protein of interest were collected after
centrifugation at 15,000 rpm for 15 min. GST-PAK 1–207 aa were expressed
using 1 mM IPTG, 37 °C for 4 h prior to protein collection. 80 μg GST-PAK[1–
207 aa] were interacted with glutathione sepharose 4B beads. Excess non-
interacting proteins were washed away by ice-cold 1× PBS followed by
incubation of the various proteins. After rotation for 3 h at 4 °C, the non-
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with ice-cold 1× PBS, the interacting proteins bound to GST-PAK 1–207 aa
were eluted. Specifically, only GTP-Rac1 or GTP-Cdc42 will interact with the
CRIB [11] and can hence be detected by the anti-HA antibodies. The
endogenous Rac1 was detected by a mouse monoclonal anti-Rac1 antibody
(Upstate, USA).
2.6. Preparation of phosphorylation protein lysates
HEK293T cells were transfected with the various constructs and incubated
in serum-free medium for 18 h. The cells were then supplemented with 5% FBS
4 h prior to protein collection. Cells were first washed with ice-cold 1 X PBS
prior to addition of lysis buffer (50 mM Tris–Cl pH8.0, 150 mM NaCl, 1 mM
EDTA, 10% NP40, 50 mM NAF, 1 mM Na3VO4) supplemented with EDTA-
free complete protease inhibitor cocktail (Roche). Lysates were collected and
subjected to brief sonication followed by clarification at 15,300 rpm for 15 min
at 4 °C. The supernatant containing the protein of interest were quantified by use
of Bradford protein assay (Bio-Rad) and 25 μg were used for western analysis.
Anti-ERK1/2 and anti-phosphorylated ERK1/2 antibodies were obtained from
BD transduction laboratories while anti-AKT and anti-phosphorylated-AKT
were obtained from Cell Signaling Technology.
2.7. Western blot analysis
Proteins collected from the above were subjected to 12% SDS-PAGE run
using an MP3 setup (Bio-Rad) followed by transferring to 0.2 μm PVDF (Bio-
Rad) at 21 V for 50 min. After transfer, the SDS-PAGE gels were stained in
Coomassie Blue while the membrane was blocked in 5% non-fat milk/PBS for
1 h. Primary antibodies were added in the concentration (1:1000–1:5000) in 3%
non-fat milk/1× PBS and allowed to interact by rotation for 1 h. After washing
twice with 0.05% Tween-20/1× PBS (15 min), various secondary antibodies
tagged with HRP (Pierce) were added in 3% of non-fat milk/1×PBS (1:10,000)
and allowed to interact for a further 1 h. After washing twice with 0.05% Tween-
20/PBS, SuperSignal West Pico chemiluminescent substrate (Pierce) were added
to the membrane and subjected to ECL using CLxposure X-ray film (Pierce).
2.8. Real-time RT-PCR
Total RNAwere collected from the various transfection by RNeasy mini kit
(Qiagen) as per manufacturer's instructions. DNaseI (NEB) was used to remove
any residual genomic and plasmid DNA prior to RT-PCR. 0.1 ng of RNAwere
then used for real-time RT-PCR analysis with designed oligonucleotides 5′-ATG
GAC ATT GAC CCT TATAAA G-3′ (Forward) as well as 5′-AGA CTC TAA
GGC TTC TCG AT-3′ (Reverse) for a segment of the pre-Core region
representative of pgRNA concentration. iScript one-step RT-PCR with SYBR
green kit (Bio-Rad) were utilized for this run. The real-time RT-PCR was carried
out in an IQ 5 multicolor Real-time PCR detection system (Bio-Rad) with
protocol as follow: 50 °C for 10 min, 95 °C for 5 min followed by 40 cycles of
the detection cycling at 95 °C for 10 s and 60 °C for 30 s.
2.9. Southern blot analysis of intracellular HBV DNA
HBV viral genomes were transfected into HepG2 cells utilizing Amaxa
Nucleofector. 5 days post transfection, viral DNA was extracted as described
[17]. Briefly, transfected cells were washed in ice-cold 1× PBS and lysed in lysis
buffer (50 mM Tris–Cl, pH 7.5, 1 mM EDTA, 1% Igepal CA630). After
resuspension with lysis buffer, cells were stood on ice for 20 min followed by
centrifugation at 14,000 rpm for 1 min to pellet the nuclei. The supernatant
containing the encapsidated viral DNA was adjusted to 10 mM MgCl2 and
treated with DNaseI (100 mg/ml) for 30 min at 37 °C to remove the non-
encapsidated DNA. EDTA concentration was then adjusted to 25 mM to stop
DNaseI activity and 0.5 mg/ml of proteinase K (in 1% SDS) were added and
incubated for 2 h at 37 °C to digest the proteins. Traditional phenol:chloroform
method was then utilized for purification of the viral DNA followed by ethanol
precipitation.
2 μg of viral DNAwas loaded onto a 1% agarose gel and electrophoresis was
performed. The gel was then denatured twice for 15 min at R.T., with shaking indenaturation solution (0.5 M NaOH, 1.5 M NaCl). The denatured gel was then
rinsed in water and subjected to neutralization twice for 15 min at R.T., with
shaking in neutralization solution (0.5 M Tris–Cl pH 7.5, 1.5 M NaCl). The gel
was then equilibrated for 10 min in equilibration buffer (20× SSC) and
transferred onto positively charged nylon membrane (GE healthcare) via passive
transfer overnight. Upon transfer, the nylon membrane was subjected to UV
crosslinking using UV Stratalinker (Stratagene). HBV probe was generated by
random prime labeling utilizing the Megaprime DNA labeling system (GE
healthcare). Briefly, full length HBV genome DNA was digested from the
pCDNA3.1+ plasmid and purified using gel extraction (Qiagen). DNA was
diluted to 2.5 ng /μl in water. 25 ng of DNA was mixed with 5 μl of supplied
primer solution and denatured by boiling for 5 min. 4 μl of various nucleotides
except dATP were added. 5 μl of Reaction buffer and 5 μl of 250 UCI Alpha-
32P dATP (Redivue, GE healthcare) were added. Finally, 2 μl of the supplied
enzyme was added and incubated at 37 °C for 15 min. Unincorporated
nucleotides were removed by purification using Sephadex G-50 spin columns
from GE healthcare as per manufacturer's instructions. Half of the reaction
volume was used for the Southern hybridization. Before preparation of the 32P
labeled probe, the nylon membrane was prehybridized in hybridization buffer
(1 M NaCl, 50 mM Tris–Cl pH 7.5, 1% SDS, 0.5 mg/ml salmon testes DNA and
10% Dextran sulfate) for 3 h at 65 °C. The labeled probe was added and allowed
to interact overnight. A series of washes from low to high stringency were
carried out with 3 increasing SSC concentration from 0.5, 1 and 2× (all with
0.1% SDS) for 15 min each at 65 °C. The labeled membrane was then wrapped
in cling foil and detection was performed using Intensifying Screen (Biorad)
overnight and scanned using a molecular Imager FX system (Bio-Rad).
3. Results and discussion
3.1. HBV replicating cells show morphological changes
A cell-based system for HBV replication has been
established [18–20]. In this study, cells transfected with the
replicative genome are examined for the morphological
changes. Fig. 1 shows an AFM image (panel A) of a typical
HepG2 cell. HBV replicating HepG2 cells show perturbations at
the cell periphery which were linked to numerous spiky
extensions as evidenced (panel B, Fig. 1). This was reminiscent
of lamellipodia or filopodia formation caused by cellular Rho
GTPases [5], as also shown in cells transfected with the
constitutively activated Rac1G12V (panel C, Fig. 1) or
Cdc42G12V (data not shown) but not the activated RhoAG14V
(data not shown). Interestingly, these spiky extensions with
average axial diameter of 80 nm were not found in pCDNA3.1+
transfected cells. Our preliminary investigation suggested a role
of HBV replication in cellular actin cytoskeleton reorganization,
and was consistent with the recent report that HIV-1 infection
resulted in enhanced adhesion of T cells through RhoA
activation [21].
3.2. Morphology of HBV replicating cells are similar to
Rac1G12V transfected cells
Actin cytoskeletal changes are modulated by the Rho
family of small GTPases, Rac1, Cdc42, and RhoA. Consti-
tutively activated forms of these proteins (Rac1G12V,
Cdc42G12V and RhoAG14V) lead to changes at the cell
periphery through actin polymerization, including membrane
rufflings/lamellipodia, filopodia and stress fibers respectively
[5]. In addition to our AFM analysis, cells transfected with
constitutively activated mutant of individual Rho GTPases
Fig. 1. AFM analysis of cell morphology in relation to HBV replication and Rho GTPases. AFM study of normal (A) pcDNA3.1+ transfected HepG2, (B) pcDNA3.1+
HBV replicative genome (rHBV) transfected HepG2 cells, and (C) cells transfected with Rac1G12V (scan area is 50 μm×50 μm). As observed, (B) HBV replicating
HepG2 cells and (C) cells transfected with Rac1G12V show perturbations at the cellular periphery compared to (A) empty vector transfected HepG2 cells.
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by phalloidin to reveal structure of actin filaments. Similar
analysis was carried out in parallel for cells transfected with
the replicative HBV genome. High transfection efficiency of
HepG2 cells were achieved by the use of Nucleofector
(Amaxa, GmBH), as shown in Fig. 2, with an average of 70%
transfection efficiency. Transfection of HepG2 cells with
activated mutants of individual Rho GTPases displayed their
respective phenotype (lamellipodia for Rac1G12V, filopodia for
Cdc42G12V and actin stress fiber for RhoG14V) as shown in the
panel of triplicates (panel A–C, Fig. 3) and evidenced by a
closer examination (panel D, Fig. 3). Interestingly, perturba-
tions to the cellular periphery were observed in higher
magnification in HBV replicating cells showing Rac1G12V-
induced ruffling-like appearances compared to the smooth
mock (pcDNA3.1+) transfected cells. Comparatively,
Cdc42G12V transfected cells showed longer protrusions
equivalent to the filopodia (Fig. 3D). RhoG14V transfected
cells on the other hand showed significantly different actin
structure with strong staining of the stress fibers. Our results
suggested that HBV replication may activate Rac1-mediated
actin polymerization process, supporting previous report onFig. 2. Transfection efficiency of HepG2 Cells by Amaxa Nucleofector. Transient t
contrast image obtained 24 h after transfection while (B) shows the corresponding exp
an Olympus IX71 fluorescent microscope and transfection efficiency was estimatedthe association between Cdc42 and Rac1 activation and HIV-1
viral replication [8].
3.3. HBV replication specifically activates Rac1
Endogenous Rho GTPases are generally locked at their
GDP-bound inactive state. Their activation triggers transduc-
tion of signal to downstream targets. In the case of Rac1 and
Cdc42, the p21-activated kinase (PAK1) is the direct effector
which contains an interactive binding (CRIB) domain recogniz-
ing specifically the activated forms (GTP bound) of Rac1 or
Cdc42 [15]. The ability of HBV replication in activating
endogenous Rho GTPases was investigated by a pull-down
assay. The GST-PAK 1–207 aa (containing the CRIB domain)
with an HA tag was expressed and used for the pull-down assay.
The efficacy of PAK1-CRIB in recognizing Rac1G12V and
Cdc42G12V was demonstrated by its ability to retain the mutant
proteins. As detected by Western blot analysis using anti-HA,
Rac1G12V (lane Rac1V12, upper section, Fig. 4A ) and
Cdc42G12V (lane Cdc42V12, upper section, Fig. 4A) from
transfected cells bound to PAK1-CRIB. As expected, no
binding was detected for the dominant negative mutants, eitherransfection of pDSRed (Clontech) vector was examined. (A) depicts the phase
ression of the red fluorescence detected. The image was digitally acquired using
to be approximately 70%.
Fig. 3. Fluorescence microscopy analysis of cell morphology in relation with HBV replication and Rho GTPases. Fluorescent microscopy pictures of HepG2 cells
transfected with (1) pCDNA3.1+ (empty vector), (2) rHBV (3) Rac1G12V (4) Cdc42G12Vand (5) RhoAG14V using Amaxa Nucleofector technology and immunostained
with Phalloidin–Alexa fluor 488 nm for actin filaments. Rows (A), (B) and (C) shows the triplicates of images taken from individual transfection while (D) depicts a
representative cropped view of the cell periphery from each of the transfection. HBV replicative genome shows increased ruffling and presence of lamellipodia
presentation comparable to that of dominant active Rac1G12V phenomenon but to a lesser extent. On the other hand, dominant active Cdc42G12Vand RhoAG14V present
physically different presentations of the filopodia and stress fibers respectively. pcDNA3.1+ acts as a negative control for HBV replicative genome transfection and
shows the typical staining of HepG2 with enhanced actin at the periphery of the cells (white bar within each picture represents length of 40 μm).
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binding for Cdc42T17N (lane Cdc42N17, upper panel, Fig. 4A).
HBV replicative genome were then co-transfected with the wild
type Rac1 (type 1 cells) and the wild type Cdc42 (type 2 cells)
separately. Positive binding of the Rac1 to the PAK-CRIB was
detected in type 1 cells (lane rHBV+Rac1, upper panel, Fig.
4A), indicating that Rac1 was activated in these cells. No band
was detected for type 2 cells, suggesting that Cdc42 was not
activated by HBV replication (lane rHBV+Cdc42, upper panel,
Fig. 4A). The significance of the detected Rac1 activation by
HBV replication was further supported by the absence of Rac1
activation in cells transfected with the pcDNA3.1 empty vector
and the wild type Rac1 (lane pcDNA+Rac1, upper panel, Fig.
4A). No binding was detected in cells transfected with the
pcDNA3.1 empty vector and thewild type Cdc42 (lane pcDNA+
Cdc42, upper panel, Fig. 4A). Taken together, our results
suggested that HBV replication led to specific activation of
Rac1. Surprisingly, Cdc42 which is an upstream activator of
Rac1 was not activated by HBV replication. Rac1 activation isrequired for maintenance of malignancy in mouse skin tumor
cells through the activation of mitogenic signaling pathways
such as ERK1/2 and AKT activation occurs downstream of
Rac1 activation [23]. Recent report has provided evidence that
HBX results in phosphorylation of ERK1/2 as well as AKT
[24]. To further validate our observation that HBV replication
leads to the Rac1 activation, the phosphorylation state of
ERK1/2 and AKT was investigated. As a positive control, the
phosphorylation state of both ERK1/2 and AKT was examined
in cells transfected with the constitutively activated mutant
Rac1G12V. Results shown in Fig. 4B revealed that in cells
expressing Rac1G12V protein (lane Rac1V12, panel E),
phosphorylation was detected for both ERK1/2 (arrowhead
ERK1/2-p, lane Rac1V12, panel A) and AKT (arrowhead
AKT-p, lane Rac1V12, panel C). For cells transfected with the
replicative HBV genome (lane rHBV, Fig. 4B), stronger
phosphorylation for ERK1/2 was detected (arrowhead ERK1/
2-p, panel A). Compared with cells producing Rac1G12V and
those transfected with the empty vector (arrowhead ERK1/2-p,
Fig. 4. Activation Rac1 and downstream effectors by HBV replication. (A) The CRIB binding assay utilizing GST fusion protein of PAK 1–207 aa which contains the
CRIB domain that binds specifically to only GTP bound Rac1 and Cdc42 (activated forms). The left panel depicts the binding assay results from Rac1 binding assay of
HBV replicative genome transfected compared to the dominant active (Rac1G12V) and dominant negative (Rac1T17N) controls by Western analysis using mouse
monoclonal anti-HA antibodies (Santa Cruz Biotech). The right panel shows the binding assay results from Cdc42 binding assay of HBV replicative genome
transfected compared to the dominant active (Cdc42G12V) and dominant negative (Cdc42T17N) controls. Bottom panel shows the loading consistency of the
corresponding binding protein, GST-PAK 1–207 aa by Coomassie Blue staining of the SDS-PAGE after Western transfer. (B) The phosphorylation status of proteins
extracted from rHBV-transfected and that of activated Rac1G12V-transfected cells. Phosphorylation antibodies for ERK1/2 (BD Transduction laboratories) and AKT
(Cell Signaling Technology) were made use of for the immunoblots. Total ERK1/2 (panel B) and AKT (panel D) were respectively immunoblotted for loading
consistency. Immunoblot using anti-HA (panel E) was used to detect the expression level of the Rac1G12V. (C) Protein lysates from pCDNA3.1+ transfected,
HepG2.2.15, rHBV-transfected cells were collected. They were then subjected to interaction with GST-bound PAK 1–207 aa containing the Cdc42/Rac1 interactive
binding domain (CRIB). Specifically, the activated Rac1 will be bound to the PAK 1–207 aa CRIB domain. As observed, Rac1 activation was not detected in
pCDNA3.1+ empty vector transfection compared to replicative genome transfected (rHBV). In addition, HepG2.2.15 showed minor activation of Rac1. Total Rac1
served as the loading control in conjunction with actin. PAK 1–207 aa serves as the control of the loading of the bait.
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significantly stronger. On the other hand, the phosphorylation
of AKT was weaker in cells transfected with the replicative
HBV genome (arrowhead AKT-p, lane rHBV, panel C) than
that in cells transfected with Rac1G12V, but significantly
stronger than that in cells transfected with the empty vector
(arrowhead AKT-p, lane pCDNA3.1, panel C). Our results
therefore indicated that both ERK1/2 and AKT were phos-
phorylated in cells transfected with the replicative HBV
genome, and provided further evidence on the Rac1 activation
by HBV replication.The ability of HBV replication to activate endogenous Rac1
was then examined, to complement our observations of co-
transfected wild type Rac1. HepG2 cells were transfected with
rHBV. A Rac1 activation CRIB assay was conducted together
with the constitutive HBV-producing HepG2.2.15 cells. As
shown in Fig. 4C, activated Rac1 was detected after CRIB in
rHBV and HepG2.2.15 cell lysates. As a negative control, no
activation of endogenous Rac1 was observed in cells transfected
with pcDNA 3.1 vector alone. Interestingly, activation of
endogenous Rac1 in HepG2.2.15 was less significant as
compared with to our transient overexpression of rHBV. This
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Fig. 6. Modulation of Cdc42 and/or Rac1 Signaling Pathway and HBV
Replication. Real-time RT-PCR was used to analyze the potential of rHBV
acting downstream of Cdc42 activation. Cdc42G12V co-transfected with rHBV
showed increased viral replication intermediate. The co-transfection of rHBV
with Cdc42G12V and Rac1T17N resulted in decreased viral replication.
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(HepG2.2.15) to the sustained HBV replication, resulting in
decreased cellular response to the virus.
3.4. Activation of Rac1 promotes HBV replication and is
independent of Cdc42
To examine whether Rac1 activation plays a role in HBV
viral replication, real-time RT-PCR analysis on the pre-Core
region of HBV indicative of viral replication [25] was carried
out. As shown in Fig. 5A, co-transfection of Rac1G12V with
the HBV replicative genome (rHBV) resulted in increased viral
pgRNA production (lane Rac1V12, Fig. 5A) compared with
rHBV transfection alone (lane rHBV, Fig. 5A). The signifi-
cance of the association between activation of Rac1 and HBV
replication was further supported by the suppression of the
increase in viral replication in cells transfected with dominant
negative mutant Rac1T17N (lane Rac1N17, Fig. 5A). Cells
transfected with either the activated mutant RhoAG14V (lane
RhoAV14, Fig. 5A) showed no significant changes in HBV
replication while cells expressing dominant negative mutant
RhoAT19N (lane RhoAN19, Fig. 5A) showed reduced HBV
replication. Our results therefore suggested that activation of
Rac1 led to an increased HBV replication. It is conceivable
that HBV replication may activate actin polymerization
mediated by Rac1 to facilitate or increase the export of
progeny viral particles. On the other hand, the increase in HBV
replication in cells transfected with Cdc42G12V (lane
Cdc42V12, Fig. 5A) was more significant compared with
that in cells tranfected with Rac1G12V. It was interesting to note
that the HBV replication level in cells transfected with
Cdc42T17N (lane Cdc42N17, Fig. 5A) remained higher than
that in cells transfected with the replicative HBV genome
alone.
To validate the results of real-time PCR, Southern blot
analysis was carried out to detect for intracellular viral DNA
from the replication of rHBV. The same experimental set was
performed as in Fig. 5A with the inclusion of HepG2.2.15 as a
positive control. As observed in panel A (Fig. 5B), HBV DNA
was detected at the 3.5 kb. The additional band (N9kb) on top of
the 3.5 kb band indicated the plasmid transfected. The results
were then tabulated as fold increase over rHBV in panel B (Fig.
5B) after subtraction of the values of pCDNA3.1 to eliminate
background interference. Consistent with our real-time PCR
results, the Southern blot analysis indicated that the HBV
replication was increased in the presence of Rac1G12V and
Cdc42G12V, with a higher level in the presence of Cdc42G12V.
As a positive control, the HBV-producing HepG2.2.15 cellsFig. 5. Effects of Rho GTPases on HBV Replication. (A) Real-time RT-PCR on HBV
rHBV viral replication from the various GTPases co-transfected with rHBV. The resul
and are the results of 3 replicates of transfection. Fold increase was calculated wi
Cdc42G12V co-transfected with rHBV gave the highest fold increase followed by th
HBV DNA using random prime labeling of full length HBV genome as probe. Pan
labeling of full length genome as probe, pCDNA3.1+ transfection was added as a neg
band can be detected above (∼9 kb) and serve as detection of genome transfection
Biorad's Quantity One software and tabulated with rHBValone and the rest as fold c
density of pCDNA3.1 (panel (A) lane 1) was subtracted from the rest of the sampleshowed the highest level of HBV DNA as the HBV replication
was under the control of the strong promoter Moloney Murine
leukemia virus (MMLV) [14].
The above results were in contrast to the situation of Rac1,
whereby HBV replication in cells transfected with Rac1T17N
was lower than that in cells transfected with the replicative HBV
genome alone. Our results suggested that the inactivation of
Cdc42-mediated pathway may not be sufficient to reduce HBV
replication. As Cdc42 activation has been reported to lead to
Rac1 activation in the cascade of events [7,26], it was possible
that HBV might act directly on Rac1 independently of upstream
Cdc42. To further examine this possibility, HBV replication was
analyzed in cells transfected either and Cdc42G12V alone (type
1), or with both Cdc42G12V and Rac1T17N (type 2). Both types
of cells were co-transfected with the replicative HBV genome.
As a control, basal level of HBV replication was obtained by
transfection with the replicative HBV genome alone. Results
indicated that the increased viral replication observed in type 1
cells (lane rHBV+pXJCdc42V12, Fig. 6A) was reduced
drastically in type 2 cells in which Rac1T17N was concurrently
produced with Cdc42G12V (lane rHBV++RacN17Cdc42V12,
Fig. 6A). Similar to results shown in Fig. 5A, the reduced HBV
replication level was comparable with the level in cellsreplication intermediate pgRNAwas used. Results represent the fold increase of
ts from the various transfections were normalized by the use of actin concurrently
th respect to rHBV alone transfected cells (tabulated as 1 fold). As observed,
at of Rac1G12V co-transfected cells. (B) Southern Blot Analysis on intracellular
el (A) Intracellular viral DNAwas extracted and detected using random primed
ative control while untreated HepG2.2.15 serves as the positive control. Plasmid
in the respective lanes. Panel (B) Quantitation of the Southern from (A) using
hanges compared to rHBValone transfected. Due to the background, the relative
s. As observed, HepG2.2.15 showed higher amount of HBV DNA.
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gested that (1) HBV replication activated Rac1, independently
of upstream Cdc42, to increase HBV replication (2) Activation
of Cdc42 may lead to the downstream Rac1 activation and
increase further the viral replication. The higher level of viral
replication by activated Cdc42 compared to activated Rac1
(Fig. 5) may be due to the more efficient cellular signaling
mechanism through a Cdc42 activation-Rac1 activation
pathway.
3.5. HBX activates endogenous Rac1 through its proline-rich
SH3 binding region
The hepatitis B virus X protein (HBX) has been previously
shown to be important for HBV viral replication [27]. A recent
report has indicated that phosphorylation of ERK1/2 as well as
AKT is found in cells transfected with HBX [24]. Importantly,
HBX has been shown to enhance cell motility and induce
migratory phenotype through a CD44-dependent manner by
rearrangements of F-actin possibly through a Rho- and/or Rac-
dependent pathway [10]. To further determine the involvement
of HBX in the HBV replication-associated Rac1 activation, cells
transfected with HBX were examined for the morphological
changes using fluorescent microscope. Results indicated that
HBX expressing cells (with punctuate localization in green,
panel A, Fig. 7A ) displayed similar membrane ruffles (white
box in panel B, and arrowhead in panel D, Fig. 7A) as those
transfected with the replicative HBV genome (Fig. 3). These
structures were not detected in cells not transfected with HBX
(without punctuate green staining, panel A, yellow box in panel
B and cells boxed in yellow in panel D, Fig. 7A). Our resultsFig. 7. Morphology analysis of cells transfected with HBX. A) Duplicates the trans
Nucleofactor. After transfection, cells were fixed with 3% paraformaldehyde. Stain
region (panel A). The same set of transfected cells were stained with phalloidin spe
structures (boxed in white, panel C). These structures were not seen in cells not transf
the same set of cells with merged stains from panel A and B. Panel D represented mag
box in panel B). Arrowhead indicated the ruffling like structures in HBX-producing
activation. HBX was cloned into pCDNA3.1+ and the respective HBXmut was const
(RP29LPGP33LGALPPASP42P43IVPTDHGAH) as numbered. pCDNA3.1+ (empty v
were subjected to interaction with GST-bound PAK 1–207 aa to differentiate activat
domain. As observed, total Rac1 before interaction was detected as control. PAK 1–20
Interestingly, activated Rac1 was detected in HBX transfected cells and to a lesser
Decrease in endogenous activated Rac1 by HBV genome with P–A mutation (HBX
acid designated at position 29, 33, 42 and 43. Essentially, the rHBV genome was muta
showed higher activation compared to the negative control, Total Rac1 served as the
the bait loading. D) Phalloidin staining of actin filmanents in HBV genome P–A (pr
HepG2 cells nucleofected with Genome P–A mut did not show morphological chan
nucleofected HepG2 cells which also did not show any significant differences from em
Partial rescue of HBV P–Amut replication by overexpression of activated Rac1 V12.
genome P–Amut was transfected alone as well as co-transfected with Rac1 V12 and R
slight increase of about 2 fold from the HBV genome P–Amut alone transfected but d
HBV genome with P–Amutant (rHBVmut) were co-transfected with pXJ (empty vec
As observed, the co-transfection of Rac1G12V showed similar trend of up-regulation i
the pXJ co-transfected cells (baseline). On the other hand, rHBVmut co-transfected wi
of the replication was observed in the rHBVmut co-transfection with Rac1G12V to abo
on intracellular viral DNA from HepG2.2.15 cells after the transfection of pXJ (bas
analyzed with Bio-Rad's QuantityOne software and the densities were obtained for
transfected with pXJ in Panel (B). As observed, Rac1 does have an impact on HBV v
expression system.therefore suggested that HBX may be directly involved in the
Rac1 activation to support HBV replication.
To further elucidate HBX in Rac1 activation, the Rac1
activation by CRIB assay was carried out on cells transfected
with either wild type HBX or mutant HBX (Pro–Ala). As a
negative control, the empty vector (pcDNA3.1+) was trans-
fected separately. Results shown in Fig. 7B indicated that the
endogenous Rac1 was activated in cells transfected with wild
type HBX (top panel, lane HBX). Interestingly, cells transfected
with mutant HBX showed significantly reduced level of
endogenous Rac1 activation (top panel, lane HBXmut) which
was comparable to that in cells transfected with the empty
vector (top panel, lane Empty Vector). To ensure the equal
amount of cellular proteins were added in the CRIB assay, Rac1
and Pak 1–207 aa proteins level was determined by Western
blot analysis. Results shown in Fig. 7B indicated that the
amount of total cellular proteins (middle panel for Rac1 level
before CRIB assay) and the bait protein (bottom panel for Pak
1–207 aa) was the same in the CRIB assay. Taken together, our
results suggested that HBX was able to activate the endogenous
Rac1.
To determine the impact of the HBX-induced activation of
Rac1 on HBV genome, a mutated genome with proline–alanine
(P–A) substitutions in the embedding HBX was generated (see
Materials and methods). The wild type rHBVand mutant rHBV
(P–A mut) were then transfected separately into HepG2 cells
and cell lysates were subjected to the CRIB assay to examine
the Rac1 activation. As observed in Fig. 7C, rHBV showed an
increased activation of endogenous Rac1 compared to cells
transfected with pcDNA3.1+ alone (lane Replicative genome,
top panel Activated Rac1). Interestingly, a significant reductionient transfection of pEGFP-C1-HBx full length into HepG2 cells using Amaxa
ing with anti-HA antibody showed the localization of HBX in the peri-nuclear
cific for actin filaments (panel B). HBX producing cells displayed ruffling like
ected with HBX (without green stain and boxed in yellow). Panel C represented
nification of HBX-producing cell (white box in panel B) and normal cell (yellow
cells. B) HBX mutation at the proline-rich region resulted in decrease of Rac1
ructed by mutation of the proline residues within the proline-rich region of HBX
ector), HBX and HBX P–Amut (HBXmut) were transfected and the cell lysates
ed Rac1 from total Rac1 through selective binding by the PAK 1–207 aa CRIB
7 aa serves as the bait and was detected with anti-FLAG antibody for bait control.
degree in HBX P–A mut and not in pCDNA3.1+ (empty) transfected cells. C)
proline-rich region RP29LPGP33LGALPPASP42P43IVPTDHGAH) in the amino
ted of the prolines as observed in Fig. 8. In contrast, the replicative HBV genome
loading control in conjunction with actin. PAK 1–207 aa served as the control of
oline to alanines) mut cells and HBX P–A mut cells. As observed in panel (A),
ges to the periphery of the cells. In parallel, panel (B) shows the HBX P–A mut
pty vector transfected cells in Fig. 3. (White line indicates a scale of 50 μm). E)
HBV genome was transfected (serving as the 100% point). In conjunction, HBV
ac1 N17 respectively. As observed above, Rac1 V12 co-transfection resulted in a
id not rescue the replication efficiency entirely. G) HBV genome (rHBV) and the
tor), Rac1T17N (dominant negative) and Rac1G12V (dominant active) respectively.
n HBV replication compared to Rac1T17N which showed a decrease compared to
th pXJ showed little or no difference to that co-transfected with Rac1T17N. Rescue
ut N0.35 fold that of rHBV wild type. H) Southern hybridization was conducted
eline control), Rac1T17N and Rac1G12V and depicted in Panel (A). The blot was
each lane and compared as fold change over the baseline control, HepG2.2.15
iral replication, in a trend similar to the results obtained from our transient HBV
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transfected with the P–A mutant rHBV (lane replicative
Genome P–A mutated, top panel Activated Rac1). Similar to
the CRIB assay on HBX (Fig. 7B), the amount of cellular
proteins in the CRIB assay was determined by measuringprotein levels for both Rac1 (second top panel Total Rac1) and
actin (bottom panel actin). In addition, the level of bait protein
(bottom panel for Pak 1–207 aa) in the CRIB assay was also
determined (panel PAK 1–207 aa). Taken together, our results
indicated the proline-rich region in HBX was involved in the
Fig. 7 (continued).
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Fig. 8. Expression of HBX proline-rich domain and identification of interacting
cellular proteins. (A) Constructs of proline-rich region of HBx (GST-PXXP-
HIS) were expressed with 6xHIS tag and used to probe for interaction with the
SH3 domains. The top panel shows the immunoblot using anti-GST while the
bottom panel shows the specific immunoblot with anti-HIS for the incorporated
C-termini 6 X HIS tag. (B) depicts the Panomics Array I after immunoblotting
using the GST-PXXP-HIS construct and detected with anti-HIS antibodies
provided. HIS only peptide serves as control within this blot and occupy the
extreme right row of duplicates A, B, C and D (21,22) as well as the bottommost
horizontal role E (1 to 20). SH3 domains of various known proteins were spotted
in duplicates (positive result is only upon the detection of signal from both spots)
on the membrane. GST D (17,18) acts as negative control. Proteins identified
through this blot include cortactin (cortical actin binding protein) A (7,8) and
βPIX (RhoGEF) C(5,6).
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replication.
To further determine if this P–A mutation of the rHBV
genome or HBX alone can revert the membrane rufflings
observed in Fig. 3 (Genome) and Fig. 7A (HBX) caused by the
respective transient transfection, the P–A mutants of rHBV
genome and HBX were transfected separately into HepG2 cells
using the Amaxa nucleofactor. Triplicates of the cells observed
after staining with Phalloidin conjugated to 488 nm was
depicted in Fig. 7D. Results indicated that the cells transfected
by either of the two mutant constructs did not display significant
changes on the membrane periphery as observed in cells
transfected with the respective wild type counterparts.
We have thus far demonstrated that HBV replication
activated the endogenous Rac1 through the proline-rich region
in its HBX protein. Furthermore, mutations in this proline-rich
region resulted in a significant reduction of Rac1 activation. It
would be expected that Rac1G12V could bypass the need for
HBX to sustain HBV replication. To this end, HBV replication
level in cells transfected with wild type rHBVand mutant rHBV
(P–A in embedding HBX) was determined by real-time RT-
PCR analysis. Separately, similar real-time PCR analysis was
carried out in cells co-transfected with rHBV P–A mutant with
Rac1G12V, as well as those with rHBV P–A mutant and
Rac1T17N. Results shown in Fig. 7E indicated that the
replication level in cells transfected with rHBV P–A mutant
was decreased to about 12%, if the replication level was
considered as 100% in cells transfected with the wild type HBV.
Interestingly, the replication level was restored to 35% in cells
co-transfected with rHBV P–A mutant with Rac1G12V. The
significance of Rac1G12V in bypassing the need for HBX in
HBV replication was further supported by the absence of
increase in cells co-transfected with rHBV P–A mutant and
Rac1T17N.
To put into context the effects of Rac1 mutants on rHBVand
rHBV P–A mutant, we conducted another series of co-
transfection and used by real-time PCR to measure the effects
on viral replication. As observed in Fig. 7F, Rac1G12V co-
transfected with wild type HBV genome resulted in an increase
of viral replication to more than 1.2 fold compared to pXJ co-
transfected with wild type HBV genome. On the other hand,
Rac1T17N co-transfected resulted in a decrease of about 0.7 fold
compared to wild type HBV genome viral replication.
Consistent with Fig. 7E, the rHBVmut (P–A mutant of HBV
genome) co-transfected with pXJ showed a significant decrease
in viral replication which was restored to a similar extent by
Rac1G12V co-transfection. Taken together, our data showed that
Rac1 played a role in mediating HBV replication and this was
mediated through the proline-rich region in HBx.
To further support our finding on the modulation of HBV
replication by Rac1, we conducted Southern analyses using the
stable HBV cell line HepG2.2.15. HepG2.2.15 cells were
transfected using Amaxa Nucleofector with 2 μg of pXJ,
Rac1T17N and Rac1G12V respectively. 48 h post-transfection, the
cells were lysed and viral HBV DNAwas extracted for Southern
analyses. The result was shown in Fig. 7G panel (A) and the
respective densities were calculated and tabulated in panel (B).Using this stable cell line, the possible experimental error from
co-transfection (rHBV and Rac1 mutants) was minimized and
results would be more reflective of the effects of Rac1 mutants
on HBV replication. As shown in panel B Fig. 7G, Rac1
mutants did show contrasting effects to HBV replication in
HepG2.2.15 cells: HepG2.2.15 cells transfected with Rac1 N17
showed a decrease of about 0.2 fold whereas the cells
transfected with Rac1 V12 showed a significant 0.4 fold
increase in HBV DNA level. This once again strengthens our
claim that Rac1 plays a role in mediating the stimulatory effect
of HBx on HBV replication.
To explain the partial rescue of HBV replication by Rac
V12 in the context of mutant HBV genome, we propose that
HBX is a very promiscuous viral protein of the HBV.
Therefore, it may have multiple roles in terms of aiding viral
replication as well as attenuation of the host cellular system.
The role of HBX may not be restricted to the activation of
Rac1. Taken together, this supports for the fact that HBX and
in particular the SH3 binding proline-rich motif is involved in
the activation of Rac1.
Fig. 9. Interaction between HBX and βPIX by GST pulldown assay. (A) Results
of mammalian expression of βPIX transfected transiently in HEK293T cells
compared to empty vector, pXJ40FLAG detected using anti-FLAG M2.
Corresponding consistency in loading was shown in the bottom panel using anti
β-actin antibodies. (B) Results of GST pull-down assay to confirm the binding
of HBX proline-rich region (GST-PXXP) to full length mammalian expressed
βPIX (lane GST-PXXP). Mutant proline-rich region of HBX with (prolines
replaced with alanine), designated as GST-AXXA, showed decreased binding to
the βPIX (lane GST-AXXA) while GST (lane GST) was used as the negative
control. Lane M indicated molecular weight marker. GST-PAK 1–207 aa (lane
GST-PAK 1–207 aa) was used as the positive control based on its binding to
βPIX (Koh et. al. [29]). The presence of band corresponding to GST-PAK 1–
207 aa protein was due to the FLAG tag in the construct which was detected by
anti-FLAG antibody. Arrowhead βPIX indicated the position of binding of both
GST-PAK and GST-PXXP proteins.
Fig. 10. Proposed mechanism of Rac1 activation by HBV replication. A
schematic diagram depicting the potential of HBV replication interfering with
Rac1 activation, potentially through HBx interaction with βPIX, leading to
morphological changes as well as activation of signaling pathways MAPK and
PI3K/AKT through phosphorylation.
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replication-associated Rac1 Activation
We have recently identified a proline-rich “PXXP” motif
within HBX protein [28], a typical characteristic of SH3 binding
proteins. We have further demonstrated the involvement of this
SH3-binding motif in the interaction of HBX with a SH3-
containing cytoskeletal protein vinexin β [19]. Similar to theidentification of vinexin β as a HBX interacting protein, the
proline-rich region of HBX was cloned and expressed as a
32 kD HA-tagged GST fusion protein (lane GST-PXXP, lower
panel, Fig. 8A ) and used to screen a TranSignal SH3 protein
array I (Panomics, USA). Results shown in Fig. 8B revealed the
presence of a number of other SH3-containing cellular proteins
including the guanine nucleotide exchange factor for Rac1
(βPIX) [29]. To confirm the interaction between HBX and
βPIX, the full length mammalian βPIX was transiently
expressed as an 85 kD FLAG-tagged protein in HEK293T
cells (lane pXJ40FLAG-βPIX, upper panel, Fig. 9A ) and used
in the GST pull-down assay. As a negative control, no band of
the same size was detected in cells transfected with the empty
vector (pXJ40FLAG, upper panel, Fig. 9A). In the pull-down
assay, the proline-rich domain in HBX as well as the same
domain with proline to alanine mutations was separately
expressed as GST fusion proteins, GST-PXXP (lane GST-
PXXP, lower panel, Fig. 9B) and GST-AXXA (lane GST-
AXXA, lower panel, Fig. 9B) respectively. Concurrently, the
GST-PAK1CRIB-FLAG fusion protein containing the binding
domain for βPIX (lane GST-PAK 1-207 aa, lower panel, Fig.
9B) was used as positive control while the GST protein (lane
GST, lower panel, Fig. 9B) was included as negative control.
The efficiency of this pull-down assay was indicated by the
detection of βPIX using the anti-FLAG antibody (arrowhead
βPIX, lane GST-PAK 1–207 aa, upper panel, Fig. 9B). The
concurrent detection of the GST-PAK1CRIB-FLAG protein
was due to the presence of the FLAG tag (arrowhead GST-PAK
1–207 aa, lane GST-PAK 1–207 aa, upper panel, Fig. 9B).
Interestingly, the proline-rich domain of HBX in the GST-
PXXP fusion protein was bound to βPIX (arrowhead βPIX,
lane GST-PXXP, upper panel, Fig. 9B). The significance of the
interaction between HBX and βPIX was indicated by the
reduction of binding of mutant protein GST-AXXA to βPIX
(arrowhead βPIX, lane GST-AXXA, upper panel, Fig. 9B). Our
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βPIX through its proline-rich region. βPIX, a RhoGEF was
previously identified to be a binding partner of PAK1 [16,30]
and plays a role in Rac1 activation downstream of activated
Cdc42 [12,26]. Hence, it is possible that HBV replicating cells
acts through the HBX protein interaction via its proline-rich
motif with βPIX. Activation of GEF activity may hence lead to
increased GTP forms of Rac1, potentiating increased viral
replication. HBV replication-induced activation of Rac1 could
also potentially lead to a change in actin cytoskeleton resulting
in transformation of liver cells, potentiating its formation of
liver carcinoma. As such, the elucidation of potential induction
pathway might be important in the therapeutic strategy for HBV
carrier, to protect them against liver diseases. Fig. 10 depicts the
potential pathway through which HBV might activate Rac1,
independently of Cdc42 activation resulting in downstream
cytoskeletal changes and increased viral replication. Under
normal circumstances, the Rho GTPases are carefully con-
trolled, essentially through the use of proteins like guanine
nucleotide exchange factor (GEF) and GTPase activating
protein (GAP) to ensure homeostasis and balance [31]. For
example the decrease in cell proliferation as well as invasive
characteristics of HCC in patients has been attributed to the
tumor suppressor gene DLC1 coding for a GAP [32]. Continued
activation of signaling transduction might lead to abnormal cell
cycle as well as cell morphology potentially leading to cancer.
Activation of Rac isoforms have been reported in various
cancers and shown to be involved in the metastases of breast
carcinoma cells [33]. For virus infection, it has been reported
that an increase in HIV replication is associated with activated
Rho GTPases [8]. Interestingly, an attenuation of Rho GTPases
leads to a reduced infectivity for HSV-1 [9]. Results from our
current study have substantiated these earlier observations.
Importantly, Rac1 was activated by HBV replication to sustain/
increase viral replication. Although beneficial to virus replica-
tion, normal cellular homeostasis has been perturbed by such an
activation which eventually leads to various liver diseases.
Taken together, HBV might affect the activation of Rac1
independently of the typical upstream Cdc42 activation leading
to the morphological appearances observed in our AFM and
immunostaining. This activation of Rac1 by HBV replication
could be in part attributed to the interaction between HBX and
βPIX. This interaction should lead to the activation of Rac1 to
the Rac1-GTP form. The downstream MAPK and PI3K
activation of Rac1 will result in the phosphorylation of
ERK1/2 and AKT respectively. Sustained activation of Rac1-
mediated signaling pathway may subsequently lead to liver
disease progression and cancer development.
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